Skip to main content

Table 4 Mode of treatment (surgery or radiotherapy) for those who underwent radical treatment according to the Cambridge Prognostic Group (CPG)

From: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

 Patients (n)Surgery (%)RT (%)Adj. RR95% CIP
CPG
 11236726 (58.7)510 (41.3)0.870.59–1.28< 0.001
 265803691 (56.1)2889 (43.9)0.840.80–0.88 
 362632488 (40.7)3775 (59 .3)0.990.92–1.08 
 410,1124133 (40.9)5979 (59.1)1  
 511,1182238 (20.1)8880 (79.9)1.261.12–1.40 
Age group (years)
 < 6051953916 (75.4)1279 (24.6)1 < 0.001
 60–6914,8437275 (49.0)7568 (51.0)1.971.68–2.30 
 70–7914,0732081 (14.8)11,992 (85.2)3.172.54–3.95 
 ≥ 80119840 (0.3)1194 (99.7)3.522.84–4.37 
Number of comorbidities (RCS Charlson score)
 027,92111,120 (39.8)16,801 (60.2)1 0.081
 151591577 (30.6)3582 (69.4)1.091.01–1.18 
 ≥ 22229579 (26.0)1650 (74.0)1.120.99–1.27 
Socioeconomic deprivation status (5th of national distribution)
 1 (least deprived)85253387 (39.7)5138 (60.3)1 0.003
 283093068 (36.9)5241 (63.1)1.050.87–1.26 
 374282771 (37.3)4657 (62.7)1.070.77–1.50 
 460672244 (37.0)3823 (63.0)1.120.74–1.67 
5 (most deprived)49801806 (36.3)3174 (63.7)1.160.72–1.88 
Ethnicity
 White32,84012,078 (36.8)20,760 (63.2)1 0.922
 Non-white24691198 (48.5)1273 (51.5)0.940.29–3.08